{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T23:21:45Z","timestamp":1793575305070,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:00:00Z","timestamp":1383177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00394-013-0599-2","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T13:03:00Z","timestamp":1383138180000},"page":"951-961","source":"Crossref","is-referenced-by-count":58,"title":["TNF\u03b1 blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study"],"prefix":"10.1007","volume":"53","author":[{"name":"on behalf of CBT-506","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Toussirot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mourot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Dehecq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Grandcl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,31]]},"reference":[{"key":"599_CR1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/rheumatology\/keh321","volume":"43","author":"LC Rall","year":"2004","unstructured":"Rall LC, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford) 43:1219\u20131223","journal-title":"Rheumatology (Oxford)"},{"key":"599_CR2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/rheumatology\/kel127","volume":"45","author":"S Marcora","year":"2006","unstructured":"Marcora S, Casanova F, Williams E, Jones J, Elamanchi R, Lemmey A (2006) Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis. Rheumatology (Oxford) 45:1385\u20131388","journal-title":"Rheumatology (Oxford)"},{"key":"599_CR3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/40.8.882","volume":"40","author":"E Toussirot","year":"2001","unstructured":"Toussirot E, Michel F, Wendling D (2001) Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 40:882\u2013888","journal-title":"Rheumatology (Oxford)"},{"key":"599_CR4","first-page":"1505","volume":"19","author":"R Roubenoff","year":"1992","unstructured":"Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB (1992) Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 19:1505\u20131510","journal-title":"J Rheumatol"},{"key":"599_CR5","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID Rincon del","year":"2001","unstructured":"del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737\u20132745","journal-title":"Arthritis Rheum"},{"key":"599_CR6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","volume":"96","author":"AH Berg","year":"2005","unstructured":"Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939\u2013949","journal-title":"Circ Res"},{"key":"599_CR7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.288.6428.1401","volume":"288","author":"B Larsson","year":"1984","unstructured":"Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G (1984) Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13\u00a0year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 288:1401\u20131404","journal-title":"Br Med J (Clin Res Ed)"},{"key":"599_CR8","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1210\/jc.2004-1222","volume":"90","author":"D Franchimont","year":"2005","unstructured":"Franchimont D, Roland S, Gustot T, Quertinmont E, Toubouti Y, Gervy MC et al (2005) Impact of infliximab on serum leptin levels in patients with Crohn\u2019s disease. J Clin Endocrinol Metab 90:3510\u20133516","journal-title":"J Clin Endocrinol Metab"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/ajcn\/84.6.1463","volume":"84","author":"SM Marcora","year":"2006","unstructured":"Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ (2006) Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 84:1463\u20131472","journal-title":"Am J Clin Nutr"},{"key":"599_CR10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10067-008-0855-7","volume":"27","author":"J Serelis","year":"2008","unstructured":"Serelis J, Kontogianni MD, Katsiougiannis S, Bletsa M, Tektonidou MG, Skopouli FN (2008) Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheumatol 27:795\u2013797","journal-title":"Clin Rheumatol"},{"key":"599_CR11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/rheumatology\/kem291","volume":"46","author":"GS Metsios","year":"2007","unstructured":"Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF et al (2007) Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) 46:1824\u20131827","journal-title":"Rheumatology (Oxford)"},{"key":"599_CR12","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1186\/ar3169","volume":"12","author":"IL Engvall","year":"2010","unstructured":"Engvall IL, Tengstrand B, Brismar K, Hafstrom I (2010) Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21\u00a0months. Arthritis Res Ther 12:R197","journal-title":"Arthritis Res Ther"},{"key":"599_CR13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/092986707780362826","volume":"14","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Streit G, Wendling D (2007) The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 14:1095\u20131100","journal-title":"Curr Med Chem"},{"key":"599_CR14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00394-012-0370-0","volume":"51","author":"R Krysiak","year":"2012","unstructured":"Krysiak R, Handzlik-Orlik G, Okopien B (2012) The role of adipokines in connective tissue diseases. Eur J Nutr 51:513\u2013528","journal-title":"Eur J Nutr"},{"key":"599_CR15","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.2174\/092986712803833119","volume":"19","author":"E Toussirot","year":"2012","unstructured":"Toussirot E, Binda D, Gueugnon C, Dumoulin G (2012) Adiponectin in autoimmune diseases. Curr Med Chem 19:5474\u20135480","journal-title":"Curr Med Chem"},{"key":"599_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"599_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"599_CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"599_CR19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/oby.2011.393","volume":"20","author":"S Kaul","year":"2012","unstructured":"Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD et al (2012) Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity 20:1313\u20131318","journal-title":"Obesity"},{"issue":"Suppl 1","key":"599_CR20","first-page":"S300","volume":"22","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Salmon C, Penfornis A, Wendling D (2007) Precision evaluation of Lunar iDXA body composition measurements (Abstract). J Bone Min Res 22(Suppl 1):S300","journal-title":"J Bone Min Res"},{"key":"599_CR21","first-page":"855","volume":"35","author":"K Briot","year":"2008","unstructured":"Briot K, Gossec L, Kolta S, Dougados M, Roux C (2008) Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 35:855\u2013861","journal-title":"J Rheumatol"},{"key":"599_CR22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e8s","year":"2012","unstructured":"Despr\u00e8s JP (2012) Body fat distribution and risk of cardiovascular disease: an update. Circulation 126:1301\u20131313","journal-title":"Circulation"},{"key":"599_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2007.01.026","volume":"380","author":"N Ouchi","year":"2007","unstructured":"Ouchi N, Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380:24\u201330","journal-title":"Clin Chim Acta"},{"key":"599_CR24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3899\/jrheum.080626","volume":"36","author":"C Popa","year":"2009","unstructured":"Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H et al (2009) Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. J Rheumatol 36:724\u2013730","journal-title":"J Rheumatol"},{"key":"599_CR25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2005.040857","volume":"65","author":"P Harle","year":"2006","unstructured":"Harle P, Sarzi-Puttini P, Cutolo M, Straub RH (2006) No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 65:970\u2013971","journal-title":"Ann Rheum Dis"},{"key":"599_CR26","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1152\/ajpendo.00089.2007","volume":"293","author":"J Lo","year":"2007","unstructured":"Lo J, Bernstein LE, Canavan B, Torriani M, Jackson MB, Ahima RS et al (2007) Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab 293:E102\u2013E109","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"599_CR27","first-page":"222","volume":"27","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR et al (2009) Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clin Exp Rheumatol 27:222\u2013228","journal-title":"Clin Exp Rheumatol"},{"key":"599_CR28","first-page":"596","volume":"26","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay MA, Llorca J, Garcia-Unzueta MT, Gonzalez-Juanatey C, De Matias JM, Martin J et al (2008) High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol 26:596\u2013603","journal-title":"Clin Exp Rheumatol"},{"key":"599_CR29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3899\/jrheum.081192","volume":"36","author":"M Lewicki","year":"2009","unstructured":"Lewicki M, Kotyla P, Kucharz E (2009) Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment. J Rheumatol 36:1346\u20131347; author reply 7","journal-title":"J Rheumatol"},{"key":"599_CR30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/s10165-007-0605-8","volume":"17","author":"N Komai","year":"2007","unstructured":"Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N (2007) Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 17:385\u2013390","journal-title":"Mod Rheumatol"},{"key":"599_CR31","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/ard.2009.114207","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Watt P, Cherry L, Welsh P, Henninger E, Dijkmans BA et al (2010) Lack of effect of TNF alpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies. Ann Rheum Dis 69:1687\u20131690","journal-title":"Ann Rheum Dis"},{"key":"599_CR32","first-page":"880","volume":"28","author":"CS Derdemezis","year":"2010","unstructured":"Derdemezis CS, Filippatos TD, Voulgari PV, Tselepis AD, Drosos AA, Kiortsis DN (2010) Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatment. Clin Exp Rheumatol 28:880\u2013883","journal-title":"Clin Exp Rheumatol"},{"key":"599_CR33","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1136\/ard.2011.152603","volume":"70","author":"L Senolt","year":"2011","unstructured":"Senolt L, Kuklova M, Cerezo LA, Hulejova H, Filkova M, Bosanska L et al (2011) Adipokine profile is modulated in subcutaneous adipose tissue by TNF alpha inhibitors in patients with rheumatoid arthritis. Ann Rheum Dis 70:2054\u20132056","journal-title":"Ann Rheum Dis"},{"key":"599_CR34","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/ard.2008.088773","volume":"67","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Gonzalez-Juanatey C, de Matias JM et al (2008) Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis 67:1644\u20131646","journal-title":"Ann Rheum Dis"},{"key":"599_CR35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1507\/endocrj.K07E-043","volume":"55","author":"K Nishida","year":"2008","unstructured":"Nishida K, Okada Y, Nawata M, Saito K, Tanaka Y (2008) Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr J 55:213\u2013216","journal-title":"Endocr J"},{"key":"599_CR36","first-page":"936","volume":"35","author":"T Nagashima","year":"2008","unstructured":"Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T et al (2008) Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol 35:936\u2013938","journal-title":"J Rheumatol"},{"key":"599_CR37","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1210\/jc.2010-1170","volume":"96","author":"TL Stanley","year":"2011","unstructured":"Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H et al (2011) TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab 96:E146\u2013E150","journal-title":"J Clin Endocrinol Metab"},{"key":"599_CR38","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/annrheumdis-2011-200646","volume":"71","author":"R Klaasen","year":"2012","unstructured":"Klaasen R, Herenius MM, Wijbrandts CA, de Jager W, van Tuyl LH, Nurmohamed MT et al (2012) Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis 71:1510\u20131516","journal-title":"Ann Rheum Dis"},{"key":"599_CR39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cyto.2005.08.003","volume":"32","author":"PJ Simon","year":"2005","unstructured":"Simon PJ, van den Pangaart PS, van Roomen CP, Boon L (2005) Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor alpha and interleukin 1 beta treated human preadipocytes are potent leptin producers. Cytokine 32:94\u2013103","journal-title":"Cytokine"},{"key":"599_CR40","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/dc05-1801","volume":"29","author":"K Hara","year":"2006","unstructured":"Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H et al (2006) Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29:1357\u20131362","journal-title":"Diabetes Care"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-013-0599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-013-0599-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-013-0599-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T16:24:03Z","timestamp":1564590243000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-013-0599-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,31]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s00394-013-0599-2","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,31]]}}}